Novartis Ag (NVS) Operating Income (2009 - 2026)
Novartis Ag's Operating Income came in at $4.75 billion for Q2 2026, down 2.3% from $4.86 billion a year earlier but up 12.2% from the prior quarter.
Novartis Ag (NVS) Operating Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Operating Income of $17.1 billion, up 2.5% year-over-year; for FY2025, it was $17.64 billion, up 20.6% from FY2024.
- Operating Income has increased in each of the last three years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
- Going back by year, Operating Income was $14.64 billion in FY2024 (+49.8%), $9.77 billion in FY2023 (+22.9%), $7.95 billion in FY2022 (-21.0%) and $10.06 billion in FY2021 (-0.9%).
- The five-year range for quarterly Operating Income is $1.76 billion (Q4 2022) to $4.86 billion (Q2 2025).
- Year-over-year, Operating Income increased in six of the last eight quarters, with growth averaging 27.1%.
- The fastest year-over-year change in Operating Income over five years came in Q3 2024 (growth of 105.8%), and the weakest in Q3 2022 (a decline of 43.5%).
- Business Quant data shows NVS's Operating Income at $4.24 billion (Q1 2026), $3.62 billion (Q4 2025) and $4.5 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.93 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 8.41 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 6.18 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 6.27 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.56 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Pfizer | 156.44 Bn | 103.79 Bn | 12.56 Bn | 5.47 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.75 Bn |
| Mar 31, 2026 | 4.24 Bn |
| Dec 31, 2025 | 3.62 Bn |
| Sep 30, 2025 | 4.50 Bn |
| Jun 30, 2025 | 4.86 Bn |
| Mar 31, 2025 | 4.66 Bn |
| Dec 31, 2024 | 3.53 Bn |
| Sep 30, 2024 | 3.63 Bn |
| Jun 30, 2024 | 4.01 Bn |
| Mar 31, 2024 | 3.37 Bn |
| Dec 31, 2023 | 2.58 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 2.81 Bn |
| Mar 31, 2023 | 2.62 Bn |
| Dec 31, 2022 | 1.76 Bn |
| Sep 30, 2022 | 1.83 Bn |
| Jun 30, 2022 | 2.23 Bn |
| Mar 31, 2022 | 2.85 Bn |
| Dec 31, 2021 | 2.56 Bn |
| Sep 30, 2021 | 3.23 Bn |
Novartis Ag Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();